StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)

Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%

Phibro Animal Health total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Phibro Animal Health's total debt was $620.52M at Mar 31, 2026. For fiscal 2025 it was $631.69M, up 102.4% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $631.69M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Jun 30, 2025$631.69M+102.4%
FY2024Jun 30, 2024$312.08M-6.5%
FY2023Jun 30, 2023$333.84M+15.9%
FY2022Jun 30, 2022$287.93M-6.0%
FY2021Jun 30, 2021$306.46M+29.4%
FY2020Jun 30, 2020$236.76M+2.9%
FY2019Jun 30, 2019$230.18M-5.0%
FY2018Jun 30, 2018$242.38M-2.3%
FY2017Jun 30, 2017$248.14M-11.7%
FY2016Jun 30, 2016$281.17M-1.9%
FY2015Jun 30, 2015$286.52M-1.0%
FY2014Jun 30, 2014$289.39M-2.8%
FY2013Jun 30, 2013$297.73M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ1 2026Mar 31, 2026$620.52M-2.3%
Q2 FY2026CQ4 2025Dec 31, 2025$624.24M-2.3%
Q1 FY2026CQ3 2025Sep 30, 2025$627.96M+112.7%
Q4 FY2025CQ2 2025Jun 30, 2025$631.69M+102.4%
Q3 FY2025CQ1 2025Mar 31, 2025$635.41M+98.1%
Q2 FY2025CQ4 2024Dec 31, 2024$639.13M+97.3%
Q1 FY2025CQ3 2024Sep 30, 2024$295.17M-10.2%
Q4 FY2024CQ2 2024Jun 30, 2024$312.08M-6.5%
Q3 FY2024CQ1 2024Mar 31, 2024$320.82M+11.2%
Q2 FY2024CQ4 2023Dec 31, 2023$323.90M+10.8%
Q1 FY2024CQ3 2023Sep 30, 2023$328.87M+11.0%
Q4 FY2023CQ2 2023Jun 30, 2023$333.84M+15.9%
Q3 FY2023CQ1 2023Mar 31, 2023$288.44M-5.9%
Q2 FY2023CQ4 2022Dec 31, 2022$292.23M-4.7%
Q1 FY2023CQ3 2022Sep 30, 2022$296.16M-3.4%
Q4 FY2022CQ2 2022Jun 30, 2022$287.93M-6.0%
Q3 FY2022CQ1 2022Mar 31, 2022$306.62M+34.7%
Q2 FY2022CQ4 2021Dec 31, 2021$306.57M+32.9%
Q1 FY2022CQ3 2021Sep 30, 2021$306.51M+31.1%
Q4 FY2021CQ2 2021Jun 30, 2021$306.46M+29.4%
Q3 FY2021CQ1 2021Mar 31, 2021$227.66M+3.0%
Q2 FY2021CQ4 2020Dec 31, 2020$230.69M+3.0%
Q1 FY2021CQ3 2020Sep 30, 2020$233.72M+2.9%
Q4 FY2020CQ2 2020Jun 30, 2020$236.76M+2.9%
Q3 FY2020CQ1 2020Mar 31, 2020$221.04M-5.2%
Q2 FY2020CQ4 2019Dec 31, 2019$224.07M-5.2%
Q1 FY2020CQ3 2019Sep 30, 2019$227.12M-5.1%
Q4 FY2019CQ2 2019Jun 30, 2019$230.18M-5.0%
Q3 FY2019CQ1 2019Mar 31, 2019$233.23M-4.4%
Q2 FY2019CQ4 2018Dec 31, 2018$236.28M-3.7%
Q1 FY2019CQ3 2018Sep 30, 2018$239.33M-3.0%
Q4 FY2018CQ2 2018Jun 30, 2018$242.38M-2.3%
Q3 FY2018CQ1 2018Mar 31, 2018$243.88M-12.7%
Q2 FY2018CQ4 2017Dec 31, 2017$245.37M-12.4%
Q1 FY2018CQ3 2017Sep 30, 2017$246.85M-12.0%
Q4 FY2017CQ2 2017Jun 30, 2017$248.14M–
Q3 FY2017CQ1 2017Mar 31, 2017$279.47M–
Q2 FY2017CQ4 2016Dec 31, 2016$280.03M–
Q1 FY2017CQ3 2016Sep 30, 2016$280.60M–

More Phibro Animal Health figures

See a number that looks wrong?